Warning letter
CocoKefir, LLC: warning letter of Nov 6, 2012
FDA warning letter 310520 · Minneapolis District Office
Key facts
| Reference number | 310520 |
|---|---|
| Company | CocoKefir, LLC |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Nov 6, 2012 |
| Posted date | Nov 6, 2012 |
| Issuing office | Minneapolis District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.260(l)(1), 111, 111.103, 111.260, 111.553, 111.560, 111.12(c), 111.70(b), 111.70(b)(3), 111.70(e), 111.75(a)(2)(ii), 111.75(h)(2) and 8 more |
| Inspection city | Medina |
| Inspection ZIP | 55340 |
| Inspection start date | May 4, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: